Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;15(7):417.
doi: 10.3390/bios15070417.

Droplet-Based Measurements of DNA-Templated Nanoclusters-Towards Point-of-Care Applications

Jonas Kluitmann  1 , Stefano Di Fiore  2 , Greta Nölke  2 , Klaus Stefan Drese  1
Affiliations

Droplet-Based Measurements of DNA-Templated Nanoclusters-Towards Point-of-Care Applications

Jonas Kluitmann et al. Biosensors (Basel). .

Abstract

In this work, we investigate the fundamental usability of fluorescent DNA-templated silver nanoclusters (DNA-AgNCs) as sensors for Point-of Care-Testing (PoCT) applications. We developed a microfluidic platform for the generation of droplets containing DNA-AgNCs in defined, different chemical environments. The droplets are read out fluorescently at two different emission wavelengths. For the pre-evaluation for the usage of biologically relevant matrices with DNA-AgNCs, the response of two different DNA-AgNCs to a variation in pH and sodium chloride concentration was acquired. Our compact and simple setup can detect DNA-AgNCs well below 100 nM and allows the characterization of the fluorescence response of DNA-based biohybrid nanosensors to changes in the chemical environment within short measurement times. The model DNA-AgNCs remain fluorescent throughout the physiologically relevant chloride concentrations and up to 150 mM. Upon shifts in pH, the DNA-AgNCs showed a complex fluorescence intensity response. The model DNA-AgNCs differ strongly in their response characteristics to the applied changes in their environments. With our work, we show the feasibility of the use of DNA-AgNCs as sensors in a simple microfluidic setup that can be used as a building block for PoCT applications while highlighting challenges in their adaption for use with biologically relevant matrices.

Keywords: DNA-templated silver nanoclusters; Point-of-CareTesting; biohybrid nanosensors; fluorescence; microfluidics; nanoclusters; segmented flow.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Schematics of the fluorescence readout cell and image of the laboratory setup. (a) Exploded view of the fluorescence flow-through measurement cell, (b) top-view of the optical setup in the measurement cell, (c) picture of the laboratory setup without computer for data logging. 1: emission LED board; 2a: filter holder; 2b: bandpass filter; 3: measurement cell slip lid; 4a: SiPM holder body; 4b: SiPM holder lid; 5: collimating lens; 6: trench for the tubing; 7: measurement cell body; 8: SiPM bias generator and amplifier module; 9: measurement cell electronics mount; 10: SiPM cable feedthrough; 11: syringe pumps; 12: droplet generator; 13: laboratory power supplies; 14: containment for the measurement cell. The LED constant current driver board and microcontroller board are not shown for clarity.
Figure 2
Figure 2
Normalized fluorescence emission spectra of the DNA-AgNCs in 20 mM NH4OAc. Excitation wavelength λex = 270 nm. The shaded ranges show the transmission windows of the bandpass filters at ODs ≤ 3 used in the setup.
Figure 3
Figure 3
The raw data of the SiPM intensity signal for the dilution of the DNA-AgNC construct Ag28b-1 for channel BP668. The encircled numbers correspond to the condition number and match those in Figure S2 and Table S2.
Figure 4
Figure 4
The concentration-dependent emission signal intensity of the DNA-AgNCs and linear fits of the datasets. (a) The signal of channel BP565 and (b) signal of channel BP668 for a dilution range of 5 µM to 12.5 nM for Ag19b-1 and Ag28b-1, respectively.
Figure 5
Figure 5
Fluorescence intensity of (a) Ag19b-1 and (b) Ag28b-1 in response to different concentrations of sodium chloride. Each datapoint consists of 33 ± 3 droplets, each representing one measurement. Error bars indicate the standard deviation.
Figure 5
Figure 5
Fluorescence intensity of (a) Ag19b-1 and (b) Ag28b-1 in response to different concentrations of sodium chloride. Each datapoint consists of 33 ± 3 droplets, each representing one measurement. Error bars indicate the standard deviation.
Figure 6
Figure 6
Fluorescence intensity of (a) Ag19b-1 and (b) Ag28b-1 in response to different pH values. Each datapoint consists of 33 ± 3 droplets, each representing one measurement. Error bars indicate the standard deviation.
Figure 7
Figure 7
Proposed sensors for ratiometric pH measurements: (a) the use of Ag19b-1 in channels BP565 and BP668 and (b) the use of Ag19b-1 in channel BP565 and Ag28b-1 in channel BP668. The values of the dashed line are measured by the secondary y-axis of the chart as indicated by the arrow.
See this image and copyright information in PMC

References

    1. Drain P.K., Dorward J., Violette L.R., Quame-Amaglo J., Thomas K.K., Samsunder N., Ngobese H., Mlisana K., Moodley P., Donnell D., et al. Point-of-Care HIV Viral Load Testing Combined with Task Shifting to Improve Treatment Outcomes (STREAM): Findings from an Open-Label, Non-Inferiority, Randomised Controlled Trial. Lancet HIV. 2020;7:e229–e237. doi: 10.1016/S2352-3018(19)30402-3. - DOI - PMC - PubMed
    1. Mercer T.R., Salit M. Testing at Scale during the COVID-19 Pandemic. Nat. Rev. Genet. 2021;22:415–426. doi: 10.1038/s41576-021-00360-w. - DOI - PMC - PubMed
    1. Hinson J.S., Rothman R.E., Carroll K., Mostafa H.H., Ghobadi K., Smith A., Martinez D., Shaw-Saliba K., Klein E., Levin S. Targeted Rapid Testing for SARS-CoV-2 in the Emergency Department Is Associated with Large Reductions in Uninfected Patient Exposure Time. J. Hosp. Infect. 2021;107:35–39. doi: 10.1016/j.jhin.2020.09.035. - DOI - PMC - PubMed
    1. Dinnes J., Sharma P., Berhane S., Van Wyk S.S., Nyaaba N., Domen J., Taylor M., Cunningham J., Davenport C., Dittrich S., et al. Rapid, Point-of-Care Antigen Tests for Diagnosis of SARS-CoV-2 Infection. Cochrane Database Syst. Rev. 2022;7:CD013705. doi: 10.1002/14651858.CD013705.pub3. - DOI - PMC - PubMed
    1. Brendish N.J., Poole S., Naidu V.V., Mansbridge C.T., Norton N.J., Wheeler H., Presland L., Kidd S., Cortes N.J., Borca F., et al. Clinical Impact of Molecular Point-of-Care Testing for Suspected COVID-19 in Hospital (COV-19POC): A Prospective, Interventional, Non-Randomised, Controlled Study. Lancet Respir. Med. 2020;8:1192–1200. doi: 10.1016/S2213-2600(20)30454-9. - DOI - PMC - PubMed

LinkOut - more resources